A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse. This is according to data presented today at ...
Cancer research is integral to advancing treatment options and developing cures for these diseases. With funding, resources, and collaboration, experts can improve their analysis and help patients.
The BRCA founder outreach study: Initial results of a digital health model. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text component.
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has enrolled the first patient in a new treatment trial to evaluate the effectiveness of adding nilotinib to standard paclitaxel chemotherapy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback